Skip to main content

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

Projects

Ensayo clínico, aleatorizado, controlado, paralelo, para evlauar la eficacia de dos técnicas de acupuntura validad en salud: Somatoacupuntura versus Auriculopuntura, como tratamiento en los pacientes diagnosticados con Síndrome de Fatiga Crónica

IP: -
Collaborators: José Alegre Martin
Funding agency: Col·legi Oficial d'Infermers/es de Barcelona
Funding: 2420
Reference: COIB-2725-12
Duration: 01/01/2013 - 31/12/2014

Ensayo clínico, aleatorizado, controlado, paralelo, doble ciego, para evaluar eficacia-seguridad de alteplasa vs uroquinasa intrapleurales como tratamiento del derrame paraneumónico complicado complejo y empiema

IP: Maria Carmen Aleman Llanso
Collaborators: Ana Vázquez Suárez, J. Bruno Montoro Ronsano, José Alegre Martin, Tomás Fernández de Sevilla Ribosa, María Deu Martín, Jordi Andreu Soriano, Teresa Soriano Sánchez, Pilar Suñe Martin, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 82885
Reference: EC07/90479
Duration: 01/11/2007 - 30/06/2011

Registro de base poblacional de los pacientes afectos del síndrome de fatiga crónica

IP: José Alegre Martin
Collaborators: Eva Ruiz Ruiz
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 38000
Reference: FMMA/14/2006
Duration: 04/05/2007 - 01/10/2010

Repercusión funcional de la alteración neurovegetativa en los pacientes con el síndrome de fatiga crónica

IP: José Alegre Martin
Collaborators: Montserrat Duran Taberna, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 51170
Reference: PI050200
Duration: 01/01/2006 - 31/12/2008

Related news

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.